Related Experiment Video
Updated: Mar 22, 2026

Automated Detection and Analysis of Exocytosis
Published on: September 11, 2021
KRAS-MEK Signaling Controls Ago2 Sorting into Exosomes
Andrew J McKenzie1, Daisuke Hoshino2, Nan Hyung Hong1
1Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Abstract:
Secretion of RNAs in extracellular vesicles is a newly recognized form of intercellular communication. A potential regulatory protein for microRNA (miRNA) secretion is the critical RNA-induced silencing complex (RISC) component Argonaute 2 (Ago2). Here, we use isogenic colon cancer cell lines to show that overactivity of KRAS due to mutation inhibits localization of Ago2 to multivesicular endosomes (MVEs) and decreases Ago2 secretion in exosomes. Mechanistically, inhibition of mitogen-activated protein kinase kinases (MEKs) I and II, but not Akt, reverses the effect of the activating KRAS mutation and leads to increased Ago2-MVE association and increased exosomal secretion of Ago2. Analysis of cells expressing mutant Ago2 constructs revealed that phosphorylation of Ago2 on serine 387 prevents Ago2-MVE interactions and reduces Ago2 secretion into exosomes. Furthermore, regulation of Ago2 exosomal sorting controls the levels of three candidate miRNAs in exosomes. These data identify a key regulatory signaling event that controls Ago2 secretion in exosomes.
Insights
Mutant KRAS disrupts Argonaute 2 (Ago2) secretion in exosomes, a key process in cell communication. Inhibiting MEK restores Ago2 exosome release, impacting microRNA levels.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Extracellular vesicles, including exosomes, mediate intercellular communication through RNA transfer.
- Argonaute 2 (Ago2), a core component of the RNA-induced silencing complex (RISC), is implicated in microRNA (miRNA) secretion.
- Aberrant KRAS signaling is common in colon cancer and may influence cellular communication pathways.
Purpose of the Study:
- To investigate the role of KRAS mutation in regulating Ago2 secretion in exosomes.
- To elucidate the molecular mechanisms by which KRAS affects Ago2 localization and exosomal release.
- To determine the impact of Ago2 exosomal sorting on miRNA levels.
Main Methods:
- Utilized isogenic colon cancer cell lines with and without KRAS mutations.
- Employed techniques to assess Ago2 localization to multivesicular endosomes (MVEs) and its secretion in exosomes.
- Investigated the effects of MEK and Akt inhibition on Ago2 trafficking and secretion.
- Analyzed Ago2 phosphorylation status and its impact on MVE interaction using mutant Ago2 constructs.
Main Results:
- Activating KRAS mutations inhibited Ago2 localization to MVEs and reduced its exosomal secretion.
- Inhibition of MEK signaling, but not Akt, reversed the KRAS-mediated inhibition of Ago2-MVE association and exosomal secretion.
- Phosphorylation of Ago2 at serine 387 was identified as a key event preventing MVE interaction and exosome release.
- Regulation of Ago2 exosomal sorting influenced the levels of specific candidate miRNAs within exosomes.
Conclusions:
- KRAS signaling, through MEK-dependent pathways, critically regulates Ago2 exosomal secretion in colon cancer cells.
- Ago2 phosphorylation at S387 is a key determinant of its sorting into exosomes.
- This pathway represents a novel mechanism controlling intercellular communication via miRNA-containing exosomes in cancer.
Related Concept Videos
Regulation of Nuclear Protein Sorting
Signal Sequences and Sorting Receptors
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Export of Misfolded Proteins out of the ER
ER Retrieval Pathway
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...

